215 related articles for article (PubMed ID: 33095659)
1. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659
[TBL] [Abstract][Full Text] [Related]
2. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
[TBL] [Abstract][Full Text] [Related]
3. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
5. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
Mazzola R; Sicignano G; Cuccia F; Vitale C; Rigo M; Giaj-Levra N; Nicosia L; Figlia V; Ricchetti F; Attinà G; Pastorello E; De Simone A; Gurrera D; Naccarato S; Ruggieri R; Alongi F
Br J Radiol; 2021 Oct; 94(1126):20210521. PubMed ID: 34283646
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes.
Mazzola R; Figlia V; Rigo M; Cuccia F; Ricchetti F; Giaj-Levra N; Nicosia L; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Alongi F
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2379-2397. PubMed ID: 32372146
[TBL] [Abstract][Full Text] [Related]
7. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
[TBL] [Abstract][Full Text] [Related]
8. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
[TBL] [Abstract][Full Text] [Related]
9. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
[TBL] [Abstract][Full Text] [Related]
10. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
[TBL] [Abstract][Full Text] [Related]
11. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a rectal spacer with prostate SABR-first UK experience.
King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
[TBL] [Abstract][Full Text] [Related]
14. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
15. The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR).
Sturt P; Suh YE; Khoo V
Med Dosim; 2022 Summer; 47(2):173-176. PubMed ID: 35277316
[TBL] [Abstract][Full Text] [Related]
16. SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer: A systematic review.
Payne HA; Pinkawa M; Peedell C; Bhattacharyya SK; Woodward E; Miller LE
Medicine (Baltimore); 2021 Dec; 100(49):e28111. PubMed ID: 34889268
[TBL] [Abstract][Full Text] [Related]
17. Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?
Byun DJ; Gorovets DJ; Jacobs LM; Happersett L; Zhang P; Pei X; Burleson S; Zhang Z; Hunt M; McBride S; Kollmeier MA; Zelefsky MJ
Radiat Oncol; 2020 Oct; 15(1):239. PubMed ID: 33066781
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
Mazzola R; Cuccia F; Figlia V; Rigo M; Nicosia L; Giaj-Levra N; Ricchetti F; Vitale C; Mantoan B; Di Paola G; De Simone A; Gurrera D; Sicignano G; Naccarato S; Ruggieri R; Alongi F
Radiol Med; 2021 Jul; 126(7):989-997. PubMed ID: 33835309
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison.
Ogita M; Yamashita H; Nozawa Y; Ozaki S; Sawayanagi S; Ohta T; Nakagawa K
Radiat Oncol; 2021 Jun; 16(1):107. PubMed ID: 34118956
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
